Post-it launches Shopping Genius widget
LONDON 3M has developed a bargain-shopping widget with the help of its Post-it brand.
Inspired by usage of the classic Post-it note as a shopping list, 3M has developed an evolution of the shopping list for the digital age called Post-it Shopping Genius. How it works: Post-it Shopping Genius sits on your computer desktop, keeping an eye on the price changes for you, locating the cheapest price, and letting you know when it changes. The customizable application enables you to choose from thousands of electricals, durables and other consumer goods, and track up to five at a time.
The application — which can be directly downloaded from http://bit.ly/Post-itGenius and is available on iGoogle, Mac OS X desktop and Windows 7 / Vista desktops — displays up-to-date prices on many thousands of products, which are searchable within the tool.
In related news, 3M announced that it is offering a monthly monetary prize of 1,000 GBP ($1,542) or the value of a user’s shopping list if less as an incentive to those who refer the Shopping Genius application to a friend.
‘Preschool is Cool: Counting with Elmo’ arrives on DVD this fall
BURBANK, Calif. Warner Home Video is bringing Sesame Street’s beloved resident, Elmo, to DVD.
“Preschool is Cool: Counting with Elmo” supports such early math skills as number recognition, counting and enumeration with the help of Elmo and his friends.
“Warner Home Video is very happy to introduce ‘Counting with Elmo, ‘our newest DVD title in Sesame Street’s new DVD set ‘Preschool is Cool,’” said Amit Desai, WHV VP family animation and partner brands marketing. “Counting is an essential tool that every preschooler must learn and there’s nobody better than the beloved Elmo and Professor Grover to show kids how fun and exciting numbers can be.”
“Preschool is Cool: Counting with Elmo” is available on DVD Sept. 14, for a suggested retail priceof $14.98.
Keryx gets orphan-drug designation for neuroblastoma treatment
NEW YORK The Food and Drug Administration has given special designation to an investigational treatment for a cancer of the nervous system that affects children.
Keryx Biopharmaceuticals announced Wednesday that it received orphan drug designation for KRX-0401 (perifosine), a treatment for neuroblastoma. No FDA-approved treatments exist for the disease.
The FDA gives orphan drug designation to investigational treatments for rare illnesses or those affecting fewer than 200,000 patients in the United States. The designation entitles the drug maker to seven years’ market exclusivity following approval, tax benefits and exemption from certain application filing fees.